Blog

We use our blog to let you know about upcoming Insight Webinars, Journal Clubs and other events, and to provide insights on topical papers and developments in the world of IPC.

Are we talking the same language? We need to watch our language when communicating AMR (and everything else for that matter)

19/05/2026

How we talk about antimicrobial resistance shapes understanding and behaviour. Rethinking AMR language can bridge the gap between awareness and meaningful action.

Read blog...

Rethinking the language of AMR: why our metaphors matter more than ever

13/05/2026

Rethinking how we talk about antimicrobial resistance, this blog explores how common metaphors such as "war", "apocalypse", and “silent threat” can mislead, and offers more effective ways to communicate AMR that support understanding, stewardship, and behaviour change.

Read blog...

Hantavirus: a primer

07/05/2026

A practical primer on hantavirus for healthcare professionals, covering transmission, incubation, case fatality rates, and IPC implications, with insights from recent outbreaks and NEJM evidence.

Read blog...

Tension between IPC risk and sustainability gain: looking for the win‑wins

06/05/2026

Exploring the tension between infection prevention and sustainability—and where real win‑wins exist, from PPE optimisation to antimicrobial stewardship.

Read blog...

Sink splash zone 2.0

05/05/2026

New evidence shows hospital sink splash zones can disperse Gram‑negative bacteria and carbapenem resistance, highlighting hidden water risks for IPC.

Read blog...

Rethinking single use: why safe reuse matters more than ever

30/04/2026

Why safe reuse in healthcare matters now: evidence shows reuse can deliver infection safety, lower carbon and more resilient supply chains.

Read blog...

Biofilms, drains, and the hidden risks in healthcare environments: disinfection strategies

29/04/2026

Why healthcare drains and biofilms matter for HCAI risk. Evidence, audience insights from IPC 2026, and practical challenges in drain disinfection strategies.

Read blog...

Travel‑associated carbapenem‑resistant organisms at a time of increasing geopolitical instability

16/04/2026

A review of new UK data on travel‑associated carbapenemase‑producing organisms (CPOs) during rising geopolitical instability, highlighting screening variation, key epidemiological trends, and implications for infection prevention and control.

Read blog...

Addressing healthcare inequalities in IPC

13/04/2026

Health inequalities drive infectious disease risk and HCAIs. Why equity matters for IPC, and how data‑led approaches can protect those at greatest risk.

Read blog...

Neisseria meningitidis: colonisation (the norm); infection (the exception)

25/03/2026

A clear, evidence‑based explainer on Neisseria meningitidis highlighting why asymptomatic colonisation is the norm, invasive meningococcal disease is the exception, and how this distinction shapes risk communication, IPC practice, and public‑health response.

Read blog...

Subscribe

Subscribe to our email list if you’d like us to let you know about future Journal Clubs, Insight Webinars, and for other updates from IPC Partners.

This website uses cookies to improve your experience. Learn more